Literature DB >> 16739213

Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.

Julien Champey1, Emmanuelle Corruble, Jacques-Eric Gottenberg, Catherine Buhl, Tania Meyer, Céline Caudmont, Elisabeth Bergé, Jacques Pellet, Patrick Hardy, Xavier Mariette.   

Abstract

OBJECTIVE: To compare pain, fatigue, and sicca symptoms; quality of life; and psychological status between patients with primary Sjögren's syndrome (SS) and those with sicca symptoms but no autoimmune features (sicca asthenia polyalgia syndrome [SAPS]), and to determine whether a psychological pattern can be detected in patients with SAPS, which could suggest psychological distress as the cause.
METHODS: This cross-sectional, prospective study included 111 patients with primary SS according to the American-European Consensus Group criteria and 65 SAPS patients with no focus on lip biopsy and no anti-SSA/SSB antibodies. Pain, fatigue, and sicca symptoms were assessed using visual analog scales; quality of life was assessed using the Short Form 36 (SF-36); and psychological distress by the Symptom Checklist-90-Revised (SCL-90-R) questionnaire.
RESULTS: No difference was observed between primary SS and SAPS patients for pain, fatigue, sicca symptoms, quality of life, and psychological status. Fatigue and pain, but not dryness, were correlated with both quality of life and psychological distress in both groups. For primary SS patients, physical and mental composite scores on the SF-36 correlated well with global severity index (GSI) scores of the SCL-90-R (r = -0.29, P = 0.006 and r = -0.61, P < 0.0001, respectively).
CONCLUSION: Patients with primary SS and SAPS do not differ in quality of life or psychological status. Although both diseases probably have a different origin, they may require the same psychological support or psychiatric care. The strong correlation between the composite physical and mental scores of the SF-36 and the GSI scores of the SCL-90-R in primary SS patients emphasizes the importance of the psychological dimension in results of the SF-36.

Entities:  

Mesh:

Year:  2006        PMID: 16739213     DOI: 10.1002/art.21990

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  sICAM-1 as potential additional parameter in the discrimination of the Sjögren syndrome and non-autoimmune sicca syndrome: a pilot study.

Authors:  Auksė Zinkevičienė; Irena Dumalakienė; Diana Mieliauskaitė; Rita Vilienė; Ieva Narkevičiūtė; Irutė Girkontaitė
Journal:  Clin Rheumatol       Date:  2019-05-31       Impact factor: 2.980

2.  Psychological distress and quality of life are improved in autoimmune patients through Tandem-Psychotherapy, combining individual hypnosis and eye movement desensitization and reprocessing (EMDR) treatment for trauma, followed by supportive-expressive group therapy.

Authors:  Maria Teresa Corsetti; Edoardo Rossi; Sofia Bonvino; Pietro Randazzo
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

3.  [Psychosomatic aspects of dry eye syndrome].

Authors:  J Nepp
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

4.  [Sjögren's syndrome. Current aspects from a rheumatological point of view].

Authors:  C Tomiak; T Dörner
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

5.  Primary Sjögren's syndrome in Moroccan patients: characteristics, fatigue and quality of life.

Authors:  Yousra Ibn Yacoub; Samira Rostom; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-07-24       Impact factor: 2.631

6.  Quality of life in women with lipoedema: a contextual behavioral approach.

Authors:  Joanna E Dudek; Wojciech Białaszek; Paweł Ostaszewski
Journal:  Qual Life Res       Date:  2015-07-28       Impact factor: 4.147

Review 7.  Depression and anxiety in dry eye disease: a systematic review and meta-analysis.

Authors:  K H Wan; L J Chen; A L Young
Journal:  Eye (Lond)       Date:  2016-08-12       Impact factor: 3.775

8.  A five-year prospective study of fatigue in primary Sjögren's syndrome.

Authors:  Karstein Haldorsen; Ingvar Bjelland; Anne Isine Bolstad; Roland Jonsson; Johan Gorgas Brun
Journal:  Arthritis Res Ther       Date:  2011-10-13       Impact factor: 5.156

9.  Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States.

Authors:  Barbara Segal; Simon J Bowman; Philip C Fox; Frederick B Vivino; Nandita Murukutla; Jeff Brodscholl; Sarika Ogale; Lachy McLean
Journal:  Health Qual Life Outcomes       Date:  2009-05-27       Impact factor: 3.186

10.  Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Authors:  Valérie Devauchelle-Pensec; Jacques-Eric Gottenberg; Sandrine Jousse-Joulin; Jean-Marie Berthelot; Aleth Perdriger; Eric Hachulla; Pierre Yves Hatron; Xavier Puechal; Véronique Le Guern; Jean Sibilia; Laurent Chiche; Vincent Goeb; Olivier Vittecoq; Claire Larroche; Anne Laure Fauchais; Gilles Hayem; Jacques Morel; Charles Zarnitsky; Jean Jacques Dubost; Philippe Dieudé; Jacques Olivier Pers; Divi Cornec; Raphaele Seror; Xavier Mariette; Emmanuel Nowak; Alain Saraux
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.